Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study

Aicardi, 1984, A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis, Ann Neurol, 15, 49, 10.1002/ana.410150109 Rice, 2007, Clinical and molecular phenotype of Aicardi-Goutieres syndrome, Am J Hum Genet, 81, 713, 10.1086/521373 Crow, 2006, Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus, Nat Genet, 38, 917, 10.1038/ng1845 Crow, 2006, Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection, Nat Genet, 38, 910, 10.1038/ng1842 Rice, 2009, Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response, Nat Genet, 41, 829, 10.1038/ng.373 Rice, 2012, Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature, Nat Genet, 44, 1243, 10.1038/ng.2414 Tolmie, 1995, The Aicardi-Goutieres syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis), J Med Genet, 32, 881, 10.1136/jmg.32.11.881 Ramesh, 2010, Intracerebral large artery disease in Aicardi-Goutieres syndrome implicates SAMHD1 in vascular homeostasis, Dev Med Child Neurol, 52, 725, 10.1111/j.1469-8749.2010.03727.x du Moulin, 2011, Cerebral vasculopathy is a common feature in Aicardi-Goutieres syndrome associated with SAMHD1 mutations, Proc Natl Acad Sci USA, 108, E232, 10.1073/pnas.1104699108 Crow, 2013, Therapies in Aicardi-Goutieres Syndrome, Clin Exp Immunol, 10.1111/cei.12115 Lebon, 1988, Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy, J Neurol Sci, 84, 201, 10.1016/0022-510X(88)90125-6 Crow, 2009, Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity, Hum Mol Genet, 18, R130, 10.1093/hmg/ddp293 Stetson, 2012, Endogenous retroelements and autoimmune disease, Curr Opin Immunol, 24, 692, 10.1016/j.coi.2012.09.007 Bennett, 2003, Interferon and granulopoiesis signatures in systemic lupus erythematosus blood, J Exp Med, 197, 711, 10.1084/jem.20021553 Baechler, 2003, Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus, Proc Natl Acad Sci USA, 100, 2610, 10.1073/pnas.0337679100 Aicardi, 2000, Systemic lupus erythematosus or Aicardi-Goutieres syndrome?, Neuropediatrics, 31, 113, 10.1055/s-2000-7533 De Laet, 2005, Phenotypic overlap between infantile systemic lupus erythematosus and Aicardi-Goutieres syndrome, Neuropediatrics, 36, 399, 10.1055/s-2005-873058 Yao, 2009, Development of potential pharmacodynamic and diagnostic markers for anti-IFN-alpha monoclonal antibody trials in systemic lupus erythematosus, Hum Genomics Proteomics, 1, 374312, 10.4061/2009/374312 Petri, 2013, Sifalimumab, a human anti-interferon-alpha monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study, Arthritis Rheum, 65, 1011, 10.1002/art.37824 Lauwerys, 2013, Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon alpha-kinoid, Arthritis Rheum, 65, 447, 10.1002/art.37785 Lebon, 1979, Early intrathecal synthesis of interferon in herpes encephalitis, Biomedicine, 31, 267 Gresser, 1974, Pronounced antiviral activity of human interferon on bovine and porcine cells, Nature, 251, 543, 10.1038/251543a0 Ankel, 1998, Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors, Virology, 251, 317, 10.1006/viro.1998.9432 Palmer, 2007, Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factors, Eur Cytokine Netw, 18, 108 Mathian, 2011, Active immunisation of human interferon alpha transgenic mice with a human interferon alpha Kinoid induces antibodies that neutralise interferon alpha in sera from patients with systemic lupus erythematosus, Ann Rheum Dis, 70, 1138, 10.1136/ard.2010.141101 Burbelo, 2009, Antibody profiling by luciferase immunoprecipitation systems (LIPS), J Vis Exp, 32, e1549 Kisand, 2008, Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes, Blood, 112, 2657, 10.1182/blood-2008-03-144634 Karner, 2013, Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice, Clin Exp Immunol, 171, 263, 10.1111/cei.12024 Lindenmann, 1957, Studies on the production, mode of action and properties of interferon, Br J Exp Pathol, 38, 551 Isaacs, 1957, Virus interference. I. The interferon, Proc R Soc Lond B Biol Sci, 147, 258, 10.1098/rspb.1957.0048 Manry, 2011, Evolutionary genetic dissection of human interferons, J Exp Med, 208, 2747, 10.1084/jem.20111680 Schoggins, 2011, A diverse range of gene products are effectors of the type I interferon antiviral response, Nature, 472, 481, 10.1038/nature09907 Gresser, 1975, Lethality of interferon preparations for newborn mice, Nature, 258, 76, 10.1038/258076a0 Gresser, 1976, Progressive glomerulonephritis in mice treated with interferon preparations at birth, Nature, 263, 402, 10.1038/263420a0 Gresser, 1980, Interferon-induced disease in mice and rats, Ann N Y Acad Sci, 350, 12, 10.1111/j.1749-6632.1980.tb20602.x Hooks, 1979, Immune interferon in the circulation of patients with autoimmune disease, N Engl J Med, 301, 5, 10.1056/NEJM197907053010102 Hooks, 1980, The role of interferon in immediate hypersensitivity and autoimmune diseases, Ann N Y Acad Sci, 350, 21, 10.1111/j.1749-6632.1980.tb20603.x Higgs, 2011, Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway, Ann Rheum Dis, 70, 2029, 10.1136/ard.2011.150326 Feng, 2006, Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus, Arthritis Rheum, 54, 2951, 10.1002/art.22044 Thurlings, 2010, Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients, Arthritis Rheum, 62, 3607, 10.1002/art.27702 McBride, 2012, Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study, Arthritis Rheum, 64, 3666, 10.1002/art.34632 Kirou, 2005, Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease, Arthritis Rheum, 52, 1491, 10.1002/art.21031 Lebon, 2002, Interferon and Aicardi-Goutieres syndrome, Eur J Paediatr Neurol, 6, A47, 10.1053/ejpn.2002.0574 Goutieres, 1998, Aicardi-Goutieres syndrome: an update and results of interferon-alpha studies, Ann Neurol, 44, 900, 10.1002/ana.410440608 Crow, 2011, Type I interferonopathies: a novel set of inborn errors of immunity, Ann N Y Acad Sci, 1238, 91, 10.1111/j.1749-6632.2011.06220.x Hasan, 2013, Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes, Nat Immunol, 14, 61, 10.1038/ni.2475